The notices it replaced
- Reissues: PA-12-088 PHS 2012-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 2 steps back: PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 3 steps back: PA-10-050 PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 4 steps back: PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Replaced by PA-13-234.
Who won it before
208 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $72,474,764 in first-year total cost, median $224,999.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-G (12)]16
- Special Emphasis Panel[ZRG1 IMST-L (11)]12
- Special Emphasis Panel[ZRG1 IMST-S (12)]12
- Special Emphasis Panel[ZRG1 IMST-J (15)]10
- Special Emphasis Panel[ZRG1 RPHB-C (10)]9
Most frequent institutions
- PHYSICAL SCIENCES, INC4
- P2D, INC.3
- PANORAMA RESEARCH, INC.3
- APTITUDE MEDICAL SYSTEMS, INC.2
- ARTIFICIAL CELL TECHNOLOGIES, INC.2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Synthetic microparticle malaria vaccine2R44AI091089-03A1 | POWELL, THOMAS J | ARTIFICIAL CELL TECHNOLOGIES, INC., CT | $1,372,308 | ZRG1 |
| 2014 | Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies2R44AI100753-02 | LAGENAUR, LAUREL A. | OSEL, INC., CA | $1,335,502 | ADDT |
| 2014 | Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation2R44DK092041-02A1 | FRANK, BRUCE HILL | THERMALIN DIABETES, LLC, OH | $1,275,297 | ZRG1 |
| 2014 | Rotating PET and linear accelerator system for PET-guided radiation therapy2R44CA153466-02A1 | MAZIN, SAMUEL | REFLEXION MEDICAL, INC., CA | $1,169,548 | ZRG1 |
| 2014 | Augmented Reality System to Teach Hemostatic Agent Use in Hemorrhage Control2R44GM100522-02 | NOVOTNY, PAUL | SIMQUEST INTERNATIONAL, LLC, MD | $1,087,913 | ZRG1 |
| 2014 | Development of a drug discovery platform for human islets2R44DK093392-02 | BUEHRER, BENJAMIN M | ZEN-BIO, INC., NC | $1,072,731 | ZRG1 |
| 2014 | Development of a High Performance Bioprocess for Eliminating 1,4-Dioxane in Water2R44ES022123-02 | SALANITRO, JOSEPH | MICROVI BIOTECH, INC., CA | $1,068,546 | ZRG1 |
| 2014 | Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive2R44DK085766-04 | CHARYTAN, DAVID MTILLES, ARNO W | SENTIEN BIOTECHNOLOGIES, INC., MA | $1,016,886 | ZRG1 |
| 2014 | Clinical Evaluation of a Long Term Implanted Glucose Sensor2R44DK077254-06 | LUCISANO, JOSEPH Y. | GLYSENS, INC., CA | $999,876 | ZRG1 |
| 2014 | Dendritic Cell-Targeted HIV Vaccine Product2R44AI095159-02A1 | KELER, TIBOR | CELLDEX THERAPEUTICS, INC., NJ | $999,540 | VACC |
| 2014 | Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds2R44DK080567-04A1 | GHATNEKAR, GAUTAM SUDHIR | XEQUEL BIO, INC., SC | $999,289 | ZRG1 |
| 2014 | Sensitive Measurement of Cardiac Troponin I at Point of Care: The Silicon BioDevi2R44HL116078-02 | FLORESCU, OCTAVIAN | SILICON BIODEVICES, INC., CA | $993,000 | ZRG1 |
| 2014 | Novel therapeutics for fatty liver disease and type-II diabetes2R44DK093345-02 | MUSSO, DAVENIEROBISZ, LIDIAYI, NA YOUNG | SOUTHEAST TECHINVENTURES, INC., NC | $909,785 | ZRG1 |
| 2014 | Plasmodium Genus and PFV Fluorescent In Situ Hybridization (FISH) Assay Kit for d2R44AI056785-04 | SHAH, JYOTSNA S | ID FISH TECHNOLOGY, INC., CA | $885,321 | ZRG1 |
| 2014 | Development and Commercialization of Nanostructured Resorbable Urogenital Grafts2R44CA136033-02 | YAO, CHANG | NANOVIS, LLC, IN | $822,303 | ZRG1 |
| 2014 | Development of a Porcine Model of Duchenne Muscular Dystrophy2R44AR061900-02A1 | ROGERS, CHRISTOPHER | EXEMPLAR GENETICS, LLC, IA | $814,243 | ZRG1 |
| 2014 | Bioengineered Recombinant FVIII2R44HL117511-02 | DENNING, GABRIELADOERING, CHRISTOPHER BRADLEYLOLLAR, JOHN S. | EXPRESSION THERAPEUTICS, GA | $809,918 | ZRG1 |
| 2014 | Antibacterial molecular coatings pre-fabricated for biologic wound dressings2R44AR061913-02A1 | AGARWAL, ANKIT | IMBED BIOSCIENCES, INC., WI | $775,221 | ZRG1 |
| 2014 | Adjustable Helmet Array for Neonatal Magnetoencephalography2R44HD074495-02 | SHAH, VISHAL K | QUSPIN, CO | $761,923 | ZRG1 |
| 2014 | Preclinical testing of the splice modulating oligonucleotide LSP-GR12R44NS076194-03A1 | LUTZ, GORDON J | LIFESPLICE PHARMA, LLC, PA | $759,114 | ZRG1 |
| 2014 | A device for rapid, painless, bedside muscle evaluation of children with neuromus2R44NS073188-03 | BOHORQUEZ, JOSE LUISZAIDMAN, CRAIG MITCHELL | MYOLEX, INC., MA | $755,700 | ZRG1 |
| 2014 | Low Cost Modular Tissue Microarray Instrument2R44CA183447-02 | JAGIELSKI, MICHAEL T | MICATU, INC., NY | $749,243 | ZRG1 |
| 2014 | Transcutaneous Energy Transmission System for Fully Implantable VADs2R44HL108415-02 | MCCABE, AARON RICHARDWEISS, WILLIAM J | MINNETRONIX, INC., MN | $748,797 | ZRG1 |
| 2014 | A Low Power Wireless Pulse Oximeter Sensor for Unobtrusive Wearable Applications2R44AG039139-02A1 | LICHTER, PATRICK | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $747,784 | ZRG1 |
| 2014 | SAMBA HIV-1 Semi-quantitative Test for resource limited settings2R44AI097120-03A1 | LEE, HELEN H | DIAGNOSTICS FOR THE REAL WORLD, LTD, CA | $747,488 | ZRG1 |
| 2014 | Multiplexed Nucleic Acid Assays2R44GM096706-03 | CHEE, MARK S. | PROGNOSYS BIOSCIENCES, INC., CA | $739,061 | ZRG1 |
| 2014 | Ubiquitin E3 ligase detection by fluorescence resonance transfer2R44GM097827-02 | STERNER, DAVID E | PROGENRA, INC., PA | $723,331 | ZRG1 |
| 2014 | Refinement of an autodissemination station for control of mosquito vectors2R44AI096563-02A1 | BANFIELD, MICHAEL GILBERTWANG, YI | BANFIELDBIO INC., WA | $722,493 | ZRG1 |
| 2014 | Cloud computing platform for virtual screening and drug discovery.2R44GM097902-02A1 | DOCKHORN, ROBERT J | B-TECH CONSULTING, LTD, PA | $681,314 | ZRG1 |
| 2014 | Molecular Kits and Software for Lymphoid Malignancy Work-ups2R44CA171469-02 | JOHNSON, DAVID SCOTT | GIGAGEN, INC., CA | $656,240 | ZRG1 |
| 2014 | LIVERCHIP - A diagnostic tool for genetic liver diseases2R44DK093214-02 | ZEMLAN, FRANK | P2D, INC., OH | $617,897 | ZRG1 |
| 2014 | Biological vector control reducing arboviruses, including Dengue and Chikungunya2R44AI098179-02 | MAINS, JAMES WILLIAM | MOSQUITOMATE, INC., KY | $610,708 | ZRG1 |
| 2014 | ZircLight: Spectrum-specific lighting for shift work2R44HL110769-02 | HEITMANN, ANNEKEMOORE-EDE, MARTIN | CIRCADIAN MANAGEMENT, INC., MA | $609,677 | ZRG1 |
| 2014 | Engineering Escherichia coli for sialylation of therapeutic proteins2R44GM093483-02 | MERRITT, JUDITH H | GLYCOBIA, INC., NY | $602,221 | ZRG1 |
| 2014 | Integration of Genomic Biomarkers with the devTOX Human Embryonic Stem Cells Scre2R44ES022114-02 | RECIO, LESLIE | INTEGRATED LABORATORY SYSTEMS, LLC, NC | $573,697 | ZRG1 |
| 2014 | A Music-Based Rehabilitation Device for Training and Assessing Hand Function2R44HD074331-02 | FRIEDMAN, NIZAN | FLINT REHABILITATION DEVICES, CA | $568,583 | MRS |
| 2014 | A Microneedle Array System for Transcutaneous Nerve Mapping2R44NS065545-03A1 | ROSS, JAMES | AXION BIOSYSTEMS, LLC, GA | $554,886 | ZRG1 |
| 2014 | Allergens and Induced Asthma: Eradicating Indoor Allergens from Dust Mites (Phase2R44ES019790-02 · under PA-12-088 | QUICK, ALLAN M. | CARBONIX, LLC, SC | $552,991 | ZRG1 |
| 2014 | iNeuron: A contemporary platform for neuroscience education2R44MH096674-03 | DUBINSKY, JANET MMICHALOWSKI, MARTIN | ADVENTIUM ENTERPRISES, MN | $539,313 | ZRG1 |
| 2014 | Fast-Switching, High-Contrast, Electrochromic Sunwear for Persons with Age-Relate2R44AG039897-02 · under PA-12-088 | CHANDRASEKHAR, PRASANNA | ASHWIN-USHAS CORPORATION, INC., NJ | $536,295 | ZRG1 |
| 2014 | Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Pr2R44NS076167-02A1 | DAS, CHAMPAK | SFC FLUIDICS, LLC, AR | $532,640 | ZRG1 |
| 2014 | Development, Production and Testing of VLP based Respiratory Syncytial Virus (RSV1R43AI108099-01A1 | GALARZA, JOSE M. | TECHNOVAX, INC., NY | $509,623 | ZRG1 |
| 2014 | Improved Noise Attenuation Foam for In the Ear Hearing and Noise Devices2R44DC011707-02A1 | OLIVEIRA, ROBERT JAMESPARISH, WILLIAM | HEARING COMPONENTS, INC., MN | $507,182 | ZRG1 |
| 2014 | Novel Modulators of LDL Metabolism2R44HL096167-02A1 | ELSHOURBAGY, NABIL A | SHIFA BIOMEDICAL CORPORATION, PA | $500,000 | ZRG1 |
| 2014 | Device for Measuring Capillary Blood Flow and the Onset of Shock2R44HL106851-02 | CHRISTIAN, JAMES F | RADIATION MONITORING DEVICES, INC., MA | $497,445 | ZRG1 |
| 2014 | Automated Large and Mid Scale Nucleic Acid Preparation2R44GM100580-02 | MACCONNELL, WILLIAM P | MACCONNELL RESEARCH CORPORATION, CA | $492,521 | ZRG1 |
| 2014 | Preclinical and Clinical Evaluation of Humanized NM94051R44HL122028-01 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $467,832 | ZRG1 |
| 2014 | Improving MPS I ERT Efficacy through Lectin-Mediated Delivery1R43NS086326-01 | CRAMER, CAROLE L.RADIN, DAVID | BIOSTRATEGIES, LC, AR | $458,316 | ZRG1 |
| 2014 | Elementary School Mindfulness-Based Substance Use Prevention Program2R44AA021342-02A1 | PARKER, ALISON ELAINE | INNOVATION RESEARCH AND TRAINING, INC., NC | $457,921 | ZRG1 |
| 2014 | Destroying the HIV-1 provirus by utilizing components of the CRISPR/Cas system1R43AI110285-01 | FANGER, MICHAEL W | CELDARA MEDICAL, LLC, NH | $451,598 | ZRG1 |
| 2014 | Identification of novel broad-spectrum Dengue antivirals1R43AI104106-01 · under PA-12-088 | HENKEL, GREGORY WILLIAM | ARISAN THERAPEUTICS, INC., CA | $449,400 | ZRG1 |
| 2014 | Electronic Alcohol Screening and Intervention in Work Settings1R44AA022570-01 · under PA-12-088 | BENNETT, JOEL B | ORGANIZATIONAL WELLNESS & LEARNING SYS, TX | $448,478 | ZRG1 |
| 2014 | Small blood pumps for small patients1R44HL118907-01A1 | SNYDER, TREVOR ARNOULTWEARDEN, PETER D | VADOVATIONS, INC., OK | $445,050 | ZRG1 |
| 2014 | Caregiver SmartTools - Improving Medication Management for the Elderly2R44AG041540-02A1 | DEITZ, DIANE K. | ISA ASSOCIATES, INC., VA | $420,040 | ZRG1 |
| 2014 | XHA-A Novel Tolerance Therapeutic for Allergic Rhinitis1R43AI104104-01A1 | FANGER, NEIL A | VIRTICI, LLC, WA | $417,336 | ZRG1 |
| 2014 | Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Viru1R43AI104007-01A1 · under PA-12-088 | JOHNSTON, BRIAN H. | SOMAGENICS, INC., CA | $389,582 | ZRG1 |
| 2014 | Prevention of HIV/AIDS and STDs in Women over Fifty2R44AG034707-02A1 | WEITZMAN, PATRICIA FLYNN | ENVIRONMENT AND HEALTH GROUP, INC., MA | $374,933 | ZRG1 |
| 2014 | A non-myeloablative conditioning regimen for hematopoietic stem cell transplantat1R43HL117576-01A1 | GEIGER, HARTMUTZHENG, YI | P2D, INC., OH | $366,718 | ZRG1 |
| 2014 | Development of a fluorescence liposomal ABCG2 Multidrug Transporter assay1R43GM109505-01 | MELCHIOR, DONALD LEE | GLSYNTHESIS, INC., MA | $363,564 | ZRG1 |
| 2014 | HT Label-Free Screening and Kinetic Analysis of Small Molecules and Biologics1R44GM109738-01 | BROOKS, BENJAMIN DELBERTGALE, BRUCEMYSZKA, DAVID G. | CARTERRA, INC., UT | $329,750 | ZRG1 |
| 2014 | Engineered Neurotensin Fragments Targeting Neuropathic Pain1R43DE025162-01A1 | DIX, THOMAS A. | JT PHARMACEUTICALS, INC., SC | $324,258 | ZRG1 |
| 2014 | Novel Hybrid Growth Factor for Immune Reconstitution in Sepsis1R43GM109620-01 | WRIGHT, SUSAN C | PANORAMA RESEARCH, INC., CA | $306,520 | ZRG1 |
| 2014 | Novel technology to remove obscuring blood from fine needle aspiration biopsies1R43GM106489-01A1 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY, LLC, NC | $304,833 | ZRG1 |
| 2014 | A novel broad-spectrum influenza vaccine1R43AI108072-01A1 | NI, YAWEI | KJ BIOSCIENCES, LLC, TX | $300,258 | ZRG1 |
| 2014 | Antifungal Compound Discovery from Metagenomes1R43AI100383-01A1 | LI, XING-CONGLILES, MARK RMEAD, DAVID ALAN | LUCIGEN CORPORATION, WI | $298,997 | ZRG1 |
| 2014 | BREATHE FREE: Smartphone Videogame-Based Incentives for Smoking Cessation1R44DA036252-01 · under PA-12-088 | RAIFF, BETHANY RRAPOZA, DARION | ENTERTAINMENT SCIENCE PLAYMATICS, JV, NC | $294,464 | ZRG1 |
| 2014 | Novel Small Molecule Multi-targeted Ligands as Therapeutics for the Treatment of1R43NS083116-01A1 | SINGH, JASBIR | JASIN DISCOVERY SOLUTIONS, INC., IL | $282,975 | ZRG1 |
| 2014 | Development of an iPSC-derived human hepatocyte platform for drug development.1R44GM109539-01 | WAMHOFF, BRIAN ROBERT | HEMOSHEAR THERAPEUTICS, LLC, VA | $281,942 | ZRG1 |
| 2014 | Target Identification of Proteins and Peptides Capable of Recruitment of Brown Ad1R43DK101205-01 | BOSS, OLIVIER | ENERGESIS PHARMACEUTICALS, INC., MA | $276,203 | ZRG1 |
| 2014 | Development of a novel clinical assay for measuring serum hepcidin levels1R43DK101264-01 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY ,INC, NC | $276,193 | ZRG1 |
| 2014 | Rapid Histone Methyltransferase Profiling with Luminescent Reporters1R43GM109726-01 | ZUTSHI, REENA | LUCEOME BIOTECHNOLOGIES, LLC, AZ | $274,561 | ZRG1 |
| 2014 | Inhibitor #2 of Protein Phosphatase 2A (I2PP2A) and Asthma1R43HL117399-01A1 | VITEK, MICHAEL PETER | COGNOSCI, INC., NC | $268,220 | ZRG1 |
| 2014 | Metalloproteinase Inhibitor For Pain and Morphine Tolerance Due To Thermal Injury1R43GM109469-01 | SUCHOLEIKI, IRVING | AQUILUS PHARMACEUTICALS, INC., MA | $261,982 | ZRG1 |
| 2014 | Targeted Inactivation of the CCR5 HIV Coreceptor with Peptide Nucleic Acids1R43AI104355-01 · under PA-12-088 | PETERSON-ROTH, ELIZABETH | L2 DIAGNOSTICS, LLC, CT | $250,298 | ZRG1 |
| 2014 | Novel Therapeutic Approach to Hypercholesterolemia Using Next-Generation DNA Sequ1R43HL121909-01 | SHIMKETS, RICHARD AUGUST | ABEOME CORPORATION, GA | $242,066 | ZRG1 |
| 2014 | Carbon Nanotube Sensor Array for Sensitive Detection of Mercury Poisoning1R43ES023707-01 | ALAM, MAKSUDUL | INNOSENSE, LLC, CA | $241,636 | ZRG1 |
| 2014 | Development of a Porcine Model of Autosomal Dominant Polycystic Kidney Disease1R43DK096808-01A1 | ROGERS, CHRISTOPHER | EXEMPLAR GENETICS, LLC, IA | $238,920 | ZRG1 |
| 2014 | Boosting the innate immune system of the lungs to prevent and treat respiratory v1R43HL118926-01A1 | SCOTT, BRENTON | PULMOTECT, INC, TX | $231,348 | ZRG1 |
| 2014 | Reliable Assays for Pentosan Polysulfate Sodium1R43HL118788-01A1 | EMBURY, STEPHEN H. | VANGUARD THERAPEUTICS, INC., CA | $226,422 | ZRG1 |
| 2014 | Fungal Metabolites as Novel Anthelmintics against Soil-Transmitted Helminthes.1R43AI100316-01A1 · under PA-12-088 | PEARCE, CEDRIC JOHN | MYCOSYNTHETIX, INC., NC | $225,000 | ZRG1 |
| 2014 | Child Safety Seat with Harness Pretensioner1R43HD083878-01A1 · under PA-12-088 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $225,000 | ZRG1 |
| 2014 | Web-Based Training in Alcohol SBIRT for Youth Aged 9-181R43AA022571-01 · under PA-12-088 | BIRNEY, AMELIA JMCPHERSON, TRACY L | OREGON CENTER FOR APPLIED SCIENCE, INC., AZ | $225,000 | ZRG1 |
| 2014 | Vasoactive Intestinal Peptide for the treatment of Female Sexual Arousal Disorder1R43AG042208-01A1 | BOLOTIN, ELIJAH M.CASTILLO, GERARDO M. | PHARMAIN CORPORATION, WA | $225,000 | ZRG1 |
| 2014 | Novel and Selective AMPK Activator for the Treatment of Hepatocellular Carcinoma1R43CA171389-01A1 | BATCHELOR, KEN W | NOVATARG, INC., NC | $225,000 | ZRG1 |
| 2014 | Low Dose Rapid Scanning Slit Digital Mammography and Breast Tomosynthesis1R44CA177093-01A1 | BARBER, WILLIAM C | DXRAY, INC., CA | $225,000 | ZRG1 |
| 2014 | Molecular Imaging of Macrophage Infiltration in Solid Cancers1R43CA183149-01 | RYCHAK, JOSHUA J. | TARGESON, INC., CA | $225,000 | ZRG1 |
| 2014 | Synthesis and evaluation of novel kinase inhibitors as anti-metastasis agents for1R43CA183195-01 | BAE, INSOOTUCCI, FABIO COHEN | EPIGEN BIOSCIENCES, INC., CA | $225,000 | ZRG1 |
| 2014 | Robust & Efficient Method for Pharmaceutical Freeze Drying in Pre-Filled Syringes1R43CA183491-01A1 | KESSLER, WILLIAM J | PHYSICAL SCIENCES, INC, MA | $225,000 | ZRG1 |
| 2014 | Direct RT-qPCR analysis of microRNAs in human plasma (miR-Direct)1R43CA177074-01A1 | KAZAKOV, SERGEI A | SOMAGENICS, INC., CA | $225,000 | ZRG1 |
| 2014 | Monobody therapy for gynecologic cancers1R43CA180330-01A1 | LARRICK, JAMES W | PANORAMA RESEARCH, INC., CA | $225,000 | ZRG1 |
| 2014 | Host-Targeted Mechanism of Action for Treatment of Seasonal and Pandemic Influenz1R43AI110048-01 | KOYUNCU, EMRE | EVRYS BIO, LLC, PA | $225,000 | ZRG1 |
| 2014 | Neuroscience Practical Applications to Reach K-12 Students (NeuroSPARKS)1R43OD018237-01 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $225,000 | ZRG1 |
| 2014 | A Wnt Modulator for Treatment of Age-related Macular Degeneration1R43EY024195-01 | CHEN, DANYANG | CHARLESSON, LLP, OK | $225,000 | ZRG1 |
| 2014 | Novel Algorithm for Free Testosterone Determination1R43AG045011-01A1 | JASUJA, RAVI | FUNCTION PROMOTING THERAPIES, LLC, MA | $225,000 | ZRG1 |
| 2014 | Selective inhibitors of deubiquitylases1R43GM109585-01 | MASON, MARK | LIFESENSORS, INC., PA | $225,000 | ZRG1 |
| 2014 | Immune-based brain cancer diagnostic for rapid, accurate disease classification1R43CA183360-01 | SYKES, KATHRYN FRANCES | HEALTHTELL, INC., AZ | $225,000 | ZRG1 |
| 2014 | FrostBite - A Unique Catheter for Endoscopic Cryoablation1R43CA183265-01 | BAUST, JOHN M | CELL PRESERVATION SERVICES, INC., NY | $225,000 | ZRG1 |
| 2014 | SGX942 to Decrease Oral Mucositis After Chemoradiation for Head and Neck Cancer1R43DE024032-01 | STRAUBE, RICHARD CONRAD | SOLIGENIX, INC., NJ | $225,000 | ZRG1 |
| 2014 | Engineering of human H-NOX as an oxygen delivery therapeutic for prolonged admini1R43CA177097-01A1 | CARY, STEPHEN | OMNIOX, INC., CA | $225,000 | ZRG1 |
| 2014 | Multiplexed Ovarian Cancer Microfluidic Tissue Microarray1R43CA177146-01A1 | BROOKS, BENJAMIN DELBERTJANAT-AMSBURY, MARGIT MARIA | CARTERRA, INC., UT | $225,000 | ZRG1 |
| 2014 | Protein Bound RNA Sequencing1R41HG007336-01A1 | TOLOUE, MASOUD | BIOO SCIENTIFIC CORPORATION, TX | $225,000 | ZRG1 |
| 2014 | Correcting Aberrant Splicing of the Human CD22 Gene1R43CA177067-01A1 | MITCHELL, LLOYD G | RETROTHERAPY, LLC, MD | $225,000 | ZRG1 |
| 2014 | Development of a Pan-HIV Proteomic Chip1R43DE025165-01 | CAMERINI, DAVID | IMMPORT THERAPEUTICS, INC., CA | $225,000 | ZRG1 |
| 2014 | Real-time assessment of surgical margins with enhanced contract optical imaging1R43CA173998-01A1 | IFTIMIA, NICUSOR | PHYSICAL SCIENCES, INC, MA | $224,999 | ZRG1 |
| 2014 | Clinically suitable approach for gene-mediated therapy of cirrhosis.1R43AA024000-01 | AGUILAR-CORDOVA, ESTUARDO | ADVANTAGENE, INC, MA | $224,999 | ZRG1 |
| 2014 | The Development of Novel Inhibitors of BCL2 Gene Expression as Anticancer Therape1R43CA183107-01 | HURLEY, LAURENCE H.SIDDIQUI-JAIN, ADAM | TETRAGENE, LLC, UT | $224,998 | ZRG1 |
| 2014 | Head-Steerable Device for Basic Vision Function1R43EY023483-01 · under PA-12-088 | ARDITI, ARIES ROBERT | VISIBILITY METRICS, LLC, NY | $224,992 | ZRG1 |
| 2014 | Novel Therapy for Tumor-induced Osteomalacia1R43AR065839-01 | LARRICK, JAMES W | PANORAMA RESEARCH, INC., CA | $224,989 | ZRG1 |
| 2014 | A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer1R44CA176937-01A1 | LI, FENGZHILING, XIANG | CANGET BIOTEKPHARMA, LLC, NY | $224,988 | ZRG1 |
| 2014 | TRAIL Upregulation by TIC10 Analogs1R43CA177002-01A1 | EL-DEIRY, WAFIK S.OLSON, GARY L | PROVID PHARMACEUTICALS, INC, NJ | $224,960 | ZRG1 |
| 2014 | Dual Targeted Human Beta Defensin for Improving Chemotherapy1R43CA183353-01 | PANDURANGI, RAGHU SPAULMURUGAN, RAMASAMY | SCI-ENGI-MEDCO SOLUTIONS, INC., MO | $224,958 | ZRG1 |
| 2014 | Integrating optical coherence tomography with laryngeal high-speed videoendoscopy1R43DC013743-01 | IFTIMIA, NICUSOR | PHYSICAL SCIENCES, INC, MA | $224,955 | ZRG1 |
| 2014 | Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery1R43GM109621-01 | LOWERY, ROBERT G | BELLBROOK LABS, LLC, WI | $224,931 | ZRG1 |
| 2014 | Cell Targeting Peptides for Isolating Patient Specific Stem Cells1R43GM108198-01A1 | LAROCCA, DANA | BIOTIME, INC., CA | $224,911 | ZRG1 |
| 2014 | User-driven Tool for Bilingual Clinical Dialogs and Medical Language Acquisition1R44MD008672-01 | TAN, WILLIAM Z | TRANSCENDENT INTERNATIONAL, LLC, NY | $224,898 | ZRG1 |
| 2014 | Development of self-delivering RNAi to evaluate PTEN as a therapeutic target to p1R43NS084489-01A1 | MCKERRACHER, LISA JWOLFSON, ALEXEY | BIOAXONE BIOSCIENCES, INC., MA | $224,789 | ZRG1 |
| 2014 | Mobile App for Self Management of Comorbid Depression and Metabolic Syndrome1R43DK100049-01A1 | BIRNEY, AMELIA J | OREGON CENTER FOR APPLIED SCIENCE, INC., AZ | $224,789 | ZRG1 |
| 2014 | Technology Enabled Specialty Pharmacy for Oral Oncology1R43CA183141-01 | DAVIS, MICHAEL SEAN | MEDICASAFE, INC., NY | $224,751 | ZRG1 |
| 2014 | A Novel Antibody Drug Conjugate for Metastatic Renal Cancer Treatment1R43CA183223-01 | PRUDENT, JAMES R. | CENTROSE, LLC, WI | $224,734 | ZRG1 |
| 2014 | Chronically Acting CFTR Inhibitor Discovery for Secretory Diarrhea and ADPKD1R43DK101209-01 | MAI, DEBORAHSCHWIEBERT, ERIK MILLS | DISCOVERYBIOMED, INC., AL | $224,700 | ZRG1 |
| 2014 | Sterculic Acid Analogs to Inhibit Macular Degeneration1R43EY024202-01 | SUTHERLAND, ALAN GORDON | L2 DIAGNOSTICS, LLC, CT | $224,700 | ZRG1 |
| 2014 | Particle display: a new paradigm in high throughput discovery of ultra-high perfo1R44GM109721-01 | GONG, QIANG | APTITUDE MEDICAL SYSTEMS, INC., CA | $224,700 | ZRG1 |
| 2014 | Targeting the Core Binding Factor tumor suppressor in MLL-fusion AML1R43CA176907-01A1 | GEIGER, HARTMUTMULLOY, JAMES C | P2D, INC., OH | $224,629 | ZRG1 |
| 2014 | CLL Mutation Detection and Monitoring from Blood using AC Electrokinetics1R43CA183414-01 | KRISHNAN, RAJARAM | BIOLOGICAL DYNAMICS, INC., CA | $224,603 | ZRG1 |
| 2014 | Calcaftor, a CFTR stabilizer for Cystic Fibrosis treatment1R43DK101304-01 | WOLFF, RONALD | CALISTA THERAPEUTICS, INC., RI | $224,550 | ZRG1 |
| 2014 | Develop extremely-high-yield (5-10x conventional methods) tissue microarray techn1R43CA183180-01 | CRAWFORD, WILLIAM SCOTT | ARRAY SCIENCE, LLC, CA | $224,303 | ZRG1 |
| 2014 | Two Degrees of Freedom of EMG-Based Proportional Control in a Hand-Wrist Prosthes1R43HD076519-01A1 | CLANCY, EDWARD A | LIBERATING TECHNOLOGIES, INC., MA | $224,243 | MRS |
| 2014 | Protection Against Chemotherapy-Induced Gastrointestinal Mucositis by a Sphingosi1R43DK101146-01 | SMITH, CHARLES D | APOGEE BIOTECHNOLOGY CORPORATION, PA | $224,116 | ZRG1 |
| 2014 | Peripheral administration of nonpeptide somatostatin agonists for ophthalmic dise1R43EY024185-01 | BETZ, STEPHEN F | CRINETICS PHARMACEUTICALS, INC., CA | $224,092 | ZRG1 |
| 2014 | Ovarian cancer therapy using CD40 Ligand (CD40L)1R43CA180323-01A1 | KORNBLUTH, RICHARD SYD | MULTIMERIC BIOTHERAPEUTICS, INC., CA | $223,899 | ZRG1 |
| 2014 | Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Managemen1R43DK101280-01 | FERGUSON, BRIAN SCOTT | APTITUDE MEDICAL SYSTEMS, INC., CA | $223,839 | ZRG1 |
| 2014 | CLFB143 Analogs to Treat Glaucoma1R43EY024170-01 | GOODFELLOW, VAL S. | CALIFIA BIO, INC., CA | $223,800 | ZRG1 |
| 2014 | Investigation of PEGylated BA-210 for RGC neuroprotection1R43EY024163-01 | MCKERRACHER, LISA J | BIOAXONE BIOSCIENCES, INC., MA | $223,651 | ZRG1 |
| 2014 | Deimmunized TLR5 Agonist for Anticancer Therapy1R43CA176966-01A1 | METT, VADIM | BUFFALO BIOLABS, LLC, NY | $223,303 | ZRG1 |
| 2014 | Development of the Partner Pain Support Program1R43NR014382-01A1 | RUEHLMAN, LINDA SUE | GOALISTICS, LLC, AZ | $223,149 | ZRG1 |
| 2014 | Head-mounted Activity Monitoring(HAM)System Fast Track1R44AG046969-01 | FAUCI, MARK A | GEN-9, INC., CA | $222,981 | ZRG1 |
| 2014 | Clinical development of 18F PET tracer for imaging VEGF receptors1R44CA177247-01A1 | BACKER, JOSEPH MPOMPER, MARTIN G | SIBTECH, INC., CT | $222,920 | ZRG1 |
| 2014 | Development of an Angiogenic T Cell Assay for Personalized Cytomics in Cardiovasc1R43HL121904-01 | JOHNSON, TODD | CYTOVAS, LLC, PA | $222,916 | ZRG1 |
| 2014 | Ubiquitin pathway inhibitors for treatment of asthma1R43AI109980-01 | SURESH, KUMAR | PROGENRA, INC., PA | $222,380 | ZRG1 |
| 2014 | Selective induction of endogenous IL10 for the treatment of uveitis1R43EY024175-01 | LIN, JACK TZU-CHIAO | ANVIL BIOSCIENCES, LLC, CA | $221,704 | ZRG1 |
| 2014 | Wireless Vagal Nerve Stimulation System for Treating Atrial Fibrillation1R43HL121970-01 | DUKE, AUSTIN ROBERT | ROSELLINI SCIENTIFIC, LLC, KY | $220,835 | ZRG1 |
| 2014 | Intraocular Aerosol Treatment for Inhibition of Proliferative Vitreoretinopathy1R43EY023504-01A1 | NAQWI, AMIR A | MSP CORPORATION, MN | $220,350 | ZRG1 |
| 2014 | Regulatory Validation of Standardized Clinical Immunohistochemistry Controls1R44CA183203-01 | BOGEN, STEVEN A | BOSTON CELL STANDARDS INC, MA | $219,202 | ZRG1 |
| 2014 | High throughput camelid antibody screening as drug discovery platform1R43GM106519-01A1 | TRAN, HIEP T | ABZYME THERAPEUTICS, LLC, PA | $218,085 | ZRG1 |
| 2014 | Novel cell-based Restorative Approach in Treatment of Diabetes-related Retinopath1R43EY023463-01A1 | MILLER, LEONARD P | TARGAZYME, INC., CA | $215,739 | ZRG1 |
| 2014 | Wireless Tibial Nerve Stimulation Therapy for Overactive Bladder1R43DK101147-01 | DUKE, AUSTIN ROBERT | ROSELLINI SCIENTIFIC, LLC, KY | $213,345 | ZRG1 |
| 2014 | GMP Synthesis and Binding Studies of a Molecular Probe to Glycosaminoglycans1R43GM109590-01 | COLBY, AARON HENRY | IONIC PHARMACEUTICALS, MA | $212,716 | ZRG1 |
| 2014 | Rapid Point-of-Care Salivary Diagnostic for Periodontal Health1R43DE024015-01 | NOVAK, MICHAEL JOHN | INNOVATIVE DIAGNOSTICS, INC., KY | $212,316 | ZRG1 |
| 2014 | Affordable Cryogen-Free Point-of-Care 1.5 T Extremity MRI1R44AR065903-01 | POURRAHIMI, SHAHIN | SUPERCONDUCTING SYSTEMS, INC, MA | $211,444 | ZRG1 |
| 2014 | A dual acting drug for enhancing radiotherapeutic benefit1R43CA180316-01A1 | NORRIS, ANDREW JOHN | BCN BIOSCIENCES, LLC, CA | $209,208 | ZRG1 |
| 2014 | Fluorescent RNA foci assay for FXTAS drug discovery1R43TR001099-01 | WU, KAREN | LUCERNA, INC., NY | $207,922 | ZRG1 |
| 2014 | Multi-modal AO-LSO Phase Gradient Imaging of the Inner Retina1R43EY023481-01 · under PA-12-088 | FERGUSON, R DANIEL | PHYSICAL SCIENCES, INC, MA | $203,154 | ZRG1 |
| 2014 | Quantitative Real-Time DNA Repair Analysis Tools1R43ES025138-01A1 | GEORGE, JAYSOBOL, ROBERT W | TREVIGEN, INC., MD | $202,050 | ZRG1 |
| 2014 | Oligonucleotide Inhibitors of DNA Methyltransferases1R43GM109507-01 | SLEDZIEWSKI, ANDREW Z | METHEOR THERAPEUTICS CORPORATION, WA | $201,941 | ZRG1 |
| 2014 | Optoacoustic tomography system for image-guided cryotherapy of prostate cancer1R43CA177148-01A1 | ERMILOV, SERGEY A | TOMOWAVE LABORATORIES, INC., TX | $200,805 | ZRG1 |
| 2014 | Confocal and Autofluorescence Imaging of Macular Degeneration using a Low Cost Di1R43EY024186-01 | GAST, THOMAS J. | AEON IMAGING, LLC, IN | $200,000 | ZRG1 |
| 2014 | Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis1R43DE024024-01 | LEE, WON YONG | GLYCOMIRA, LLC, UT | $199,997 | ZRG1 |
| 2014 | A microRNA based prognostic service that predicts melanoma metastasis likelihood1R43CA183092-01 | KURTH, ISABEL | RGENIX, INC., NY | $199,654 | ZRG1 |
| 2014 | Building an open-source cloud-based computational platform to improve data access1R43DA036970-01 | MIKHEEV, MAXIM | BIODATOMICS, LLC, MD | $195,584 | ZRG1 |
| 2014 | Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support1R43AG046944-01 | SHEIKH, SUNEEL ISMAIL | ASTER LABS, INC., MN | $194,366 | ZRG1 |
| 2014 | Ion Channel Screening Using Photoswitches1R44GM109601-01 | BLATZ, ANDREW | PHOTOSWITCH BIOSCIENCES, INC., CA | $193,349 | ZRG1 |
| 2014 | Genetically Encoded Fragment-based Drug Discovery1R43GM109641-01 | MURRAY, CHRISTOPHER | GALEN BIOTECHNOLOGIES, LLC, CA | $192,941 | ZRG1 |
| 2014 | Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer1R43CA183379-01 | CARTER, DARRICK ALBERT | PAI LIFE SCIENCES, INC., WA | $191,159 | ZRG1 |
| 2014 | A Phase I trial combining IV fenretinide and IV safingol to target overproduction1R44CA183316-01 | SIMPSON, WILLIAM JAY | CERRX, INC., TX | $190,601 | ZRG1 |
| 2014 | Development of Transporter Targeted Platinum Drugs for Pediatric Tumor1R43CA183186-01 | MAMELOK, RICHARD D | APRICITY THERAPEUTICS, INC., CA | $190,000 | ZRG1 |
| 2014 | Cell Line Panel Profiling for Discovery of Multiple Myeloma Therapeutics1R43CA183470-01 | KRUTZIK, PETER | PRIMITY, INC., CA | $189,655 | ZRG1 |
| 2014 | A Biological Small Angle X-ray Scattering Station (BioSAXS) for the Compact Light1R43GM109703-01 | LOEWEN, RODERICK J | LYNCEAN TECHNOLOGIES, INC., CA | $189,385 | ZRG1 |
| 2014 | Development of a new anti-inflammatory peptide for treatment of type II diabetes1R43DK101203-01 | MOGELSVANG, SOREN | SERPIN PHARMA, LLC, VA | $188,508 | ZRG1 |
| 2014 | Novel Biodegradable Injectable Rod for Improved AMD Therapy1R43EY024199-01 | CAMPOCHIARO, PETER AYANG, MING | GRAYBUG, LLC, MD | $187,358 | ZRG1 |
| 2014 | Cytometry Reagent Database and Automated Panel Design Software.1R43GM105262-01A1 | HANKEL, ISAIAH | FLUORISH, LLC, OR | $185,858 | ZRG1 |
| 2014 | Novel Polymer Matrix for Dental Applications1R43DE024013-01 | BOLSKAR, ROBERT D | TDA RESEARCH, INC., CO | $182,536 | ZRG1 |
| 2014 | Copper Nanoparticle Impregnated, Nitric Oxide Generating Hollow Fibers for Artifi1R43HL121946-01 | MONTOYA, JEAN | MEDARRAY, INC., MI | $177,596 | ZRG1 |
| 2014 | High Integrity and High Yield DNA Extraction Using a Nanostructured Surface1R43GM109618-01 | LIU, KELVINWANG, TZA-HUEI JEFF | CIRCULOMICS, INC., MD | $175,054 | ZRG1 |
| 2014 | Lateral Flow Immunoassay for Therapeutic Monoclonal Antibody Quality Assurance1R43CA183241-01 | MESSMER, BRADLEY T | ABREOS BIOSCIENCES, INC., CA | $172,406 | ZRG1 |
| 2014 | Fully Automatic ROP Screening System: NeoScan1R43EY023474-01A1 | BARRIGA, EDUARDO SIMON | VISIONQUEST BIOMEDICAL, LLC, NM | $172,341 | ZRG1 |
| 2014 | Discovery of inhibitors of the metabolic oncogene 3-phosphoglycerate dehydrogenas1R43CA176897-01A1 | OLSZEWSKI, KELLEN LEONARD | KADMON CORPORATION, LLC, NY | $172,052 | ZRG1 |
| 2014 | Imaging cellular therapy for stress urinary incontinence1R43HD079116-01 | WESA, AMY K | CELSENSE, INC., PA | $169,296 | ZRG1 |
| 2014 | Microfluidic screening devices for health-span extending drugs1R43AG047020-01 | LOCKERY, SHAWN RMCCORMICK, KATHRYN EWEEKS, JANIS CHRISTINE | NEMAMETRIX, INC., OR | $158,406 | ZRG1 |
| 2014 | ACOUSTOPHORETIC TRANSFUSION TO REDUCE EMBOLIZATION IN CARDIOPULMONARY BYPASS1R43HL118833-01A1 | MASI, LOUIS | FLODESIGN SONICS, INC., MA | $157,332 | ZRG1 |
| 2014 | Novel Eye Dropper to Improve Adherence of Glaucoma Medicine Administration1R43EY022515-01A1 | MOSLER, THEODORE JAY | GILERO, LLC, NC | $156,324 | ZRG1 |
| 2014 | Development of Salivary Analyte Stabilizers1R43DE024026-01 | GRANGER, STEVEN W | SALIMETRICS, LLC, PA | $156,002 | ZRG1 |
| 2014 | ADSC Isolation by MMPs1R43GM106469-01A1 | ZYLBERBERG, CLAUDIA | AKRON BIOTECHNOLOGY, LLC, FL | $154,043 | ZRG1 |
| 2014 | RNA-Guided Gene Targeting in Human Cells1R43GM106537-01A1 | WANG, JIWU | ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, CA | $153,057 | ZRG1 |
| 2014 | Comprehensive Assessment of Retinal Vasculature (CARV)1R43EY024169-01 | JOSHI, VINAYAK S | VISIONQUEST BIOMEDICAL, LLC, NM | $152,268 | ZRG1 |
| 2014 | Novel flavonoids as anti-inflammatory agents in alcoholism1R43AA021038-01 · under PA-11-096 | LITTLETON, JOHN M. | NAPROGENIX, INC, KY | $150,900 | ZRG1 |
| 2014 | Liquid Helium Bath Free, Conduction Cooled Nb3Sn Superconducting 7 Tesla Plus Mag1R44CA192503-01 | PENG, XUAN | HYPER TECH RESEARCH, INC., OH | $150,291 | ZRG1 |
| 2014 | Parents.Cope: A tool for Parents of Adolescents with T1DM1R43DK098857-01A1 | MARCEAU, LISA D | NEW ENGLAND RESEARCH INSTITUTES, INC., DE | $150,000 | ZRG1 |
| 2014 | Improved Probe Tips for Biomedical Atomic Force Microscopy via Batch Wafer-Scale1R43GM109606-01 | LOCKLEDGE, SCOTT POTTER | TIPTEK, LLC, PA | $150,000 | ZRG1 |
| 2014 | Automated system for unbiased and high yield preparation and quantitation of genomic samples1R43HG007620-01 | HIDDESSEN, AMY | PURIGEN BIOSYSTEMS, INC., CA | $150,000 | ZRG1 |
| 2014 | Real-time qPCR assay for detection of ALT associated telomeric C-circle DNA in bl1R43CA168124-01A1 | MALYKH, ANDREI G. | CAPITAL BIOSCIENCES, INC., MD | $150,000 | ZRG1 |
| 2014 | Restaurant Training to Improve Menu Labeling Accuracy and Public Health Impact1R43DP005370-01A1 | LOPEZ, NANETTE | HEALTHY DINING INC, FL | $150,000 | ZDP1 |
| 2014 | Self-Digitization Microfluidic Device for Digital PCR1R43EB018125-01 | KREUTZ, JASON EUGENE | LAMPROGEN, INC., WA | $149,995 | ZRG1 |
| 2014 | ASD Parent Trainer: Online coaching for parents of children with autism (APT)1R43MH102845-01 | CARAWAY, NELL | IRIS MEDIA, INC., OR | $149,992 | ZRG1 |
| 2014 | Mobile Older Driver Assessment and Training Simulator (MODATS)1R43AG046951-01 | ROSENTHAL, THEODORE J. | SYSTEMS TECHNOLOGY, INC., CA | $149,986 | ZRG1 |
| 2014 | Large-Area Plasma Panel Detectors for Particle Beam Radiation Therapy1R43CA183437-01 | FRIEDMAN, PETER S | INTEGRATED SENSORS, LLC, FL | $149,975 | ZRG1 |
| 2014 | Micromachined microphones with in-plane and out-of-plane directivity1R43DC013746-01 | GARCIA, CAESAR THEODOREHALL, NEAL ALLEN | SILICON AUDIO, INC., TX | $149,828 | ZRG1 |
| 2014 | New HILIC Materials for Separating Polar Drugs, Biologics, and Metabolites1R43GM106488-01A1 | LEE, JAUH TZUOH | AZYP, LLC, TX | $149,800 | ZRG1 |
| 2014 | Semiconducting Polymer Dots for Multiplexed Assays1R43GM109564-01 | YU, JIANGBO | LAMPROGEN, INC., WA | $148,552 | ZRG1 |
| 2014 | Engineering cells for concurrent protein drug biosynthesis and polysialylation1R43GM109504-01 | GEISLER, CHRISTOPH | GLYCOBAC, LLC, WY | $148,202 | ZRG1 |
| 2014 | Improving Interlock Compliance with Computerized Education and Monitoring Systems1R44AA022853-01 | KELLEY-BAKER, TARA DROTH, MICHAEL | AXXESS UNLIMITED, LLC, AZ | $147,151 | ZRG1 |
Showing the 200 most recent of 208 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.